scholarly article | Q13442814 |
P356 | DOI | 10.1007/S10096-014-2211-Y |
P698 | PubMed publication ID | 25082186 |
P50 | author | Elisabetta Blasi | Q54196302 |
Massimo Girardis | Q57080256 | ||
Carlotta F Orsi | Q59662392 | ||
P2093 | author name string | F Forghieri | |
C Venturelli | |||
F Luppi | |||
P Pini | |||
C Bettua | |||
L Faglioni | |||
S Bigliardi | |||
P2860 | cites work | Invasive aspergillosis in critically ill patients without malignancy | Q80269940 |
Galactomannan detection for invasive aspergillosis in immunocompromized patients | Q24240734 | ||
Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans | Q28265703 | ||
Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012 | Q28284276 | ||
Invasive aspergillosis in the intensive care unit | Q28306909 | ||
Evaluation of PCR for detection of DNA specific for Aspergillus species in sera of patients with various forms of pulmonary aspergillosis. | Q33685971 | ||
Factors associated with mortality in transplant patients with invasive aspergillosis | Q33867013 | ||
Critical stages of extracting DNA from Aspergillus fumigatus in whole-blood specimens | Q34190354 | ||
Systematic review and meta-analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis | Q34385038 | ||
Evaluation of MycAssay™ Aspergillus for diagnosis of invasive pulmonary aspergillosis in patients without hematological cancer | Q34688953 | ||
Evaluation of analytical and preliminary clinical performance of Myconostica MycAssay Aspergillus when testing serum specimens for diagnosis of invasive Aspergillosis | Q35066867 | ||
Evaluation of Aspergillus PCR protocols for testing serum specimens | Q35530598 | ||
Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay | Q35599066 | ||
Diagnostic accuracy of serum 1,3-β-D-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis. | Q35668212 | ||
Invasive fungal infections in patients with hematologic malignancies (aurora project): lights and shadows during 18-months surveillance | Q35719482 | ||
Current status of fungal cell wall components in the immunodiagnostics of invasive fungal infections in humans: galactomannan, mannan and (1-->3)-beta-D-glucan antigens | Q36900157 | ||
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/ | Q37164067 | ||
Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis | Q37380385 | ||
Diagnosing invasive aspergillosis during antifungal therapy by PCR analysis of blood samples | Q39990268 | ||
Correlation between high-resolution computed tomography and galactomannan antigenemia in adult hematologic patients at risk for invasive aspergillosis. | Q40419516 | ||
Invasive fungal infections in the intensive care unit: a multicentre, prospective, observational study in Italy (2006-2008). | Q44020369 | ||
International study of the prevalence and outcomes of infection in intensive care units | Q44988294 | ||
Combined real-time PCR and galactomannan surveillance improves diagnosis of invasive aspergillosis in high risk patients with haematological malignancies | Q45286729 | ||
European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update | Q46050924 | ||
Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay | Q46503389 | ||
Performance of 2 commercial real-time polymerase chain reaction assays for the detection of Aspergillus and Pneumocystis DNA in bronchoalveolar lavage fluid samples from critical care patients | Q46960195 | ||
Pulmonary aspergillosis: early diagnosis improves survival | Q70877231 | ||
P433 | issue | 1 | |
P304 | page(s) | 131-136 | |
P577 | publication date | 2014-08-01 | |
P1433 | published in | European Journal of Clinical Microbiology & Infectious Diseases | Q15754378 |
P1476 | title | Clinical performance of a commercial real-time PCR assay for Aspergillus DNA detection in serum samples from high-risk patients: comparison with a galactomannan enzyme immunoassay | |
P478 | volume | 34 |
Q49307735 | Diagnostic Modalities for Invasive Mould Infections among Hematopoietic Stem Cell Transplant and Solid Organ Recipients: Performance Characteristics and Practical Roles in the Clinic |
Q52689844 | Evaluation of Two Commercial Real-Time PCR Kits for Aspergillus DNA Detection in Bronchoalveolar Lavage Fluid in Patients with Invasive Pulmonary Aspergillosis. |
Q40948260 | Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors. |
Q90429595 | Invasive mould infections in solid organ transplant patients: modifiers and indicators of disease and treatment response |
Q37363385 | Molecular Diagnostic Testing for Aspergillus |
Q54217644 | Overview of Commercially Available PCR Assays for the Detection of Aspergillus spp. DNA in Patient Samples. |
Q49245587 | PCR Technology for Detection of Invasive Aspergillosis |
Q51511753 | Quantitative Real-Time PCR and Platelia Galactomannan Assay for the Diagnosis of Invasive Pulmonary Aspergillosis: Bronchoalveolar Lavage Fluid Performs Better Than Serum in Non-neutropaenic Patients. |
Search more.